Physician‐initiated first‐in‐human clinical study using a novel angiogenic peptide, AG30/5C, for patients with severe limb ulcers

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Geriatrics & Gerontology International

• Publication date

  2017-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/ggi.13051PMID 28488306
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment with LL‐37 is safe and effective in enhancing healing of hard‐to‐heal venous leg ulcers: a randomized, placebo‐controlled clinical trial

  2014cited by this paper
• Novel Anti-Microbial Peptide SR-0379 Accelerates Wound Healing via the PI3 Kinase/Akt/mTOR Pathway

  2014cited by this paper
• A Randomized Controlled Trial to Evaluate an Antimicrobial Dressing with Silver Alginate Powder for the Management of Chronic Wounds Exhibiting Signs of Critical Colonization

  2012cited by this paper
• Modification of a novel angiogenic peptide, AG30, for the development of novel therapeutic agents

  2012cited by this paper
• The clinical efficacy of two semi‐quantitative wound‐swabbing techniques in identifying the causative organism(s) in infected cutaneous wounds

  2011cited by this paper
• Structure, membrane orientation, mechanism, and function of pexiganan--a highly potent antimicrobial peptide designed from magainin.

  2009cited by this paper
• Development of a novel antimicrobial peptide, AG-30, with angiogenic properties

  2008cited by this paper
• APD2: the updated antimicrobial peptide database and its application in peptide design

  2008cited by this paper
• Antimicrobial peptides: an essential component of the skin defensive barrier.

  2006cited by this paper
• Emerging new drugs for wound repair

  2006cited by this paper
• Bacteria and wound healing

  2004cited by this paper
• An angiogenic role for the human peptide antibiotic LL-37/hCAP-18.

  2003cited by this paper
• Defensins: antimicrobial peptides of innate immunity

  2003cited by this paper
• PR39, a peptide regulator of angiogenesis

  2000cited by this paper
• Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic Ulcer Study Group.

  1995cited by this paper
• Effect of Topical Basic Fibroblast Growth Factor on the Healing of Chronic Diabetic Neuropathic Ulcer of the foot: A pilot, randomized, double-blind, placebo-controlled study

  1995cited by this paper
• Platelet-derived growth factor BB for the treatment of chronic pressure ulcers.

  1992cited by this paper
• Basic fibroblast growth factor stimulation of epidermal wound healing in pigs.

  1990cited by this paper
• Comparison of the effects of moist and dry conditions on dermal repair.

  1988cited by this paper

• Genetic Determinants of Wound Healing: Monogenic Disorders and Polygenic Influence

  2026cites this paper
• Peptides in wound healing: A comprehensive review of their roles, challenges, and hydrogel-based delivery systems

  2025cites this paper
• Antimicrobial Peptides for Skin Wound Healing

  2025influential citation
• Peptides and Wound Healing: From Monomer to Combination

  2024cites this paper
• Werner syndrome induced pluripotent stem cells, a study of pathologic aging

  2020cites this paper
• Genetic correction of Werner syndrome gene reveals impaired pro‐angiogenic function and HGF insufficiency in mesenchymal stem cells

  2020cites this paper
• Investigator‐initiated clinical study of a functional peptide, SR‐0379, for limb ulcers of patients with Werner syndrome as a pilot study

  2019cites this paper
• Physician-initiated clinical study of limb ulcers treated with a functional peptide, SR-0379: from discovery to a randomized, double-blind, placebo-controlled trial

  2018cites this paper
• Delivery systems of current biologicals for the treatment of chronic cutaneous wounds and severe burns

  2018cites this paper
• Skin wound healing in humans and mice: Challenges in translational research.

  2017cites this paper